PubMed COVID-19 Clinical Care
38981 - 38990 of 57753 results found
Multidimensional futuristic approaches to address the pandemics beyond COVID-19
Description
Globally, the impact of the coronavirus disease 2019 (COVID-19) pandemic has been enormous and unrelenting with ∼6.9 million deaths and ∼765 million infections. This review mainly focuses on the recent advances and potentially novel molecular tools
COVID-19 Infection in Hidradenitis Suppurativa Patients: A Retrospective Study
Description
CONCLUSION: Our findings support the growing evidence that having HS itself may not be a risk factor for severe COVID-19 outcomes.
Mutual information networks reveal evolutionary relationships within the influenza A virus polymerase
Description
The influenza A virus (IAV) RNA polymerase is an essential driver of IAV evolution. Mutations that the polymerase introduces into viral genome segments during replication are the ultimate source of genetic variation, including within the three
Psychometric evaluation of PHQ-9 and GAD-7 among community health volunteers and nurses/midwives in Kenya following a nation-wide telephonic survey
Description
CONCLUSION: The PHQ-9 and GAD-7 are unidimensional, reliable, and valid tools for screening depression and anxiety among nurses/midwives and CHVs. The tools can be administered in a similar population or study setting using either Swahili or English.
Getting groceries during the pandemic: How transit remained important despite the rise of e-delivery
Description
BACKGROUND: We model the use of public transit to reach grocery stores and the use of online delivery services to get groceries, before and during the COVID-19 pandemic among people who used transit regularly prior to the crisis.
Adverse sequelae of the COVID -19 pandemic on mental health services in Chile
Description
CONCLUSIONS: The COVID-19 pandemic has had significant and enduring adverse effects on mental health care. Lessons learned can inform recommendations for good practices for the ongoing and future pandemics and health crises, and highlight the
Interferons in COVID-19: missed opportunities to prove efficacy in clinical phase III trials?
Description
Interferons were repeatedly used in the therapy of COVID-19 due to their antiviral effects. Three recently published randomized controlled clinical phase III trials (WHO SOLIDARITY, ACTT-3, and SPRINTER) missed their primary objectives, i.e., a
SARS-CoV-2 and gastrointestinal diseases
Description
CONCLUSION: This review summarizes the gastrointestinal diseases caused by SARS-CoV-2, including gastrointestinal inflammatory disorders, gastrointestinal ulcer diseases, gastrointestinal bleeding, and gastrointestinal thrombotic diseases, etc
Assessment of Post-Vaccination Immunologic Responses in Inactivated Virus COVID-19 Respondents
Description
CONCLUSION: It has been evident that IgG and IgM antibody response could be induced by inactivated SARS-CoV-2 vaccine which can be influenced by age and detection time after the second dose of vaccination. Boosters, however, must be given after six
